| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3f4526fdbf9d019c69c6ba524b81a50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbf5dfc8b342e9ab389a1247d9b21986
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_443d8767b4067e28045d45ed72fd06bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_088f62222056266f89dbb11b67360143 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-552 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2000-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e53824f3ada0a74a27e6445c890fe18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9833a349c4023970067187ba149e2f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00bb56a273e7f0cfadd25bec59c2f08c |
| publicationDate |
2001-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0066174-A3 |
| titleOfInvention |
Compounds |
| abstract |
An adduct contains Clarithromycin and Ranitidine either in the form of a base or a base hydrate in which the molar ratio of Clarithromycin to Ranitidine in the adduct is at least 2:1. The adduct has high stability and is particularly useful in a single dose formulation for the treatment of gastrointestinal disorders. |
| priorityDate |
1999-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |